The drugs PAB make seem to work.
Just cant make the drugs yet after many, many years and many, many shareholder dollars.
I'm sure if they have a manufacture breakthrough, so will the share price.
My gut feeling is they cant mass produce IgM antibodies at scale consistently.
This is the reason to move into CAR-T cells and a sp. below 2 cents.
Ann: Patrys 2014 AGM Presentation, page-26
-
- There are more pages in this discussion • 43 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.001(7.69%) |
Mkt cap ! $13.37M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.7¢ | 0.7¢ | $15.24K | 2.197M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 437079 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 2000000 | 2 |
View Market Depth
| Last trade - 14.48pm 23/07/2024 (20 minute delay) ? |
| PAB (ASX) Chart |